Global Postoperative Nausea and Vomiting Market Size to grow USD 2471.1 Billion by 2030 | CAGR of 3.55%

Global Postoperative Nausea and Vomiting Market to Exceed $2471.3 Million by 2030

According to a research report published by Spherical Insights & Consulting, The Global Postoperative Nausea and Vomiting Market Size is to grow from USD 1805.6 Million in 2021 to USD 2471.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.55% during the forecast period. The increasing adoption of postoperative nausea and vomiting by different treatment such as serotonin antagonists, dopamine antagonists, steroids, NK-1 receptor antagonists, non-pharmacological treatment and others is the key driving factor.

Browse key industry insights spread across 200 pages with 130 market data tables and figures & charts from the report on the "Global Seasonal Influenza Market Size, Share, and COVID-19 Impact Analysis, By Treatment Type (Serotonin Antagonists, Dopamine Antagonists, Steroids, NK-1 Receptor Antagonists, Non-Pharmacological Treatment), By Distribution Channels (Hospitals, Retails Pharmacies, Online Distribution, Hyper, Super Markets), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030." Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/postoperative-nausea-and-vomiting-market

Postoperative nausea and vomiting (PONV) are amongst the most common complication in patients undergoing surgery with general anesthesia. With the growing trend towards ambulatory and daycare surgery, postoperative nausea and vomiting are complex and serious problems in nausea and vomiting in anesthesia practice. In medicine, surgery after anesthesia nausea, and vomiting are suffering symptoms. The global postoperative nausea and vomiting (PONV) market is expanding rapidly due to the increasing incidence rate of postoperative complications and rising demand for combination therapy, as well as the introduction of promising drugs in this segment globally.

COVID 19 Impact

The COVID-19 pandemic had a positive impact on the Global Postoperative Nausea and Vomiting market. The increased cases of SARS-CoV-2 have boosted the use of antiemetics to treat nausea and vomiting induced by COVID-19 or any other medication. For example, in 2021, the study titled “Current Knowledge and recent advances in Intracellular Emetic Signalling System" published in The International Journal of Clinical Practice, it was observed that the use of PONV drug was severely increased during COVID-19 to treat nausea and vomiting.

The serotonin antagonists segment is accounted the largest market share over the forecast period.

Based on treatment type, the global postoperative nausea and vomiting market is segmented into serotonin antagonists, dopamine antagonists, steroids, NK-1 receptor antagonists, and non-pharmacological treatment.  Among these, the serotonin antagonists segment is dominating the market with the largest market share due to its safety profile and effectiveness as well as the physician gives first preference to the drug treatment in the management of postoperative nausea and vomiting.

In the treatment of postoperative nausea and vomiting, pharmacological anti-emetics for prophylaxis of postoperative nausea and vomiting in adults the drugs included in this segment are, serotonin antagonists; such as ramosetron, granisetron, palonosetron, ondansetron, dolasetron, and tropisetron.

The hospital segment is dominating the market over the forecast period.

Based on the distribution channel, the global postoperative nausea and vomiting market is classified into hospitals, retails pharmacies, online distribution, hyper, and super markets. Among these, the hospital segment is dominating the market over the forecast period due to the rising investment in the hospital sector, particularly in emerging countries, which is boosting the number of hospitals.

North America is accounting the market with the largest market share during the forecast period

North America accounted largest market share over the forecast period due to the presence of major key players, continuous technological development, a well-developed healthcare sector, increase healthcare awareness, and the rising prevalence of the disease. Moreover, a presence of several local pharmaceutical companies in this region is expected to grow the market in the North American region.

Europe is also expected second leading region with the largest market share growth of the postoperative nausea and vomiting market owing to rising surgical patient rates and a rise in R &D expenditure in pharmaceuticals. Rising compliances with pharmacological and non-pharmacological treatments are attributing to the growth of the market in this region.

Major vendors in the Global Postoperative Nausea and Vomiting Market include Novartis AG, GlaxoSmithKline plc, Merck and Co., Pfizer, Inc., Bayer AG, AstraZeneca, AbbVie, Sanofi, Boehringer Ingelheim Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd, Ani Pharmaceuticals, Inc., Camurus AB, Eisai Corporation, and many others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development

• In September 2019, Aloxi, Zuplenz, and Emend, these three therapies approved in the U.S. after 2000, for the treatment of postoperative nausea and vomiting. According to the U.S. Prescription information, the PONV indication was detached from the Emend capsule. However, it remains listed on the label of generic aprepitant capsules. Other PONV medications that have been discontinued in the US include Kytril, Phenergan, and Compazine. The generic versions of the majority therapies approved prior to 2000 are now utilized for management of Postoperative nausea and vomiting market.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the Global Postoperative Nausea and Vomiting Market based on the below mentioned segments:

Global Postoperative Nausea and Vomiting Market, By Treatment Type

• Serotonin Antagonists
• Dopamine Antagonists
• Steroids
• NK-1 Receptor Antagonists
• Non-Pharmacological Treatment

Global Postoperative Nausea and Vomiting Market, By Distribution Channel

• Hospitals
• Retails Pharmacies
• Online Distribution
• Hyper and Super Markets

Global Postoperative Nausea and Vomiting Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter